Invention Grant
- Patent Title: Anti-TMPRSS2 antibodies and antigen-binding fragments
-
Application No.: US17171941Application Date: 2021-02-09
-
Publication No.: US11999799B2Publication Date: 2024-06-04
- Inventor: Alina Baum , Christos Kyratsous , Lisa Purcell
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: REGENERON PHARMACEUTICALS, INC.
- Current Assignee: REGENERON PHARMACEUTICALS, INC.
- Current Assignee Address: US NY Tarrytown
- Agency: FisherBroyles, LLP
- Agent Cara L. Crowley-Weber; Gabriele Amodeo
- Main IPC: C07K16/40
- IPC: C07K16/40 ; A61K39/39 ; A61K39/395 ; A61K45/06 ; C12N9/50
Abstract:
The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to TMPRSS2 and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infections or influenza virus infections).
Public/Granted literature
- US20210246226A1 ANTI-TMPRSS2 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS Public/Granted day:2021-08-12
Information query
